Stephen Farrand, Ph.D., is an industry veteran with more than 25 years of experience and unparalleled knowledge of clinical and commercial therapeutic protein process and manufacturing, most notably having played a leadership role for the development and first approval of Keytruda®, while serving as vice president, bioprocess development at Merck. In addition to his former role at Merck, Dr. Farrand is the former senior vice president, head of global manufacturing at NantKwest, where he was responsible for establishing process and development manufacturing capabilities for NantKwest’s cell therapy products. Prior to that, Dr. Farrand was vice president, global biologics & sterile product development at Schering-Plough Research Institute, before the company was acquired by Merck in 2009, and earlier, served as manufacturing director at Schering-Plough Manufacturing sites in Ireland & Singapore. Prior to Schering-Plough, Dr. Farrand held a variety of production and manufacturing positions at Delta Biotechnology, Ltd., Sigma Chemical Co. Ltd. and G D Searle & Co. Ltd.

Stephen Farrand, Ph.D., is an industry veteran with more than 25 years of experience and unparalleled knowledge of clinical and commercial therapeutic protein process and manufacturing, most notably having played a leadership role for the development and first approval of Keytruda®, while serving as vice president, bioprocess development at Merck. In addition to his former role at Merck, Dr. Farrand is the former senior vice president, head of global manufacturing at NantKwest, where he was responsible for establishing process and development manufacturing capabilities for NantKwest’s cell therapy products. Prior to that, Dr. Farrand was vice president, global biologics & sterile product development at Schering-Plough Research Institute, before the company was acquired by Merck in 2009, and earlier, served as manufacturing director at Schering-Plough Manufacturing sites in Ireland & Singapore. Prior to Schering-Plough, Dr. Farrand held a variety of production and manufacturing positions at Delta Biotechnology, Ltd., Sigma Chemical Co. Ltd. and G D Searle & Co. Ltd.